Skip to main content
Tag

Rinitis alérgica

Recent developments and highlights in allergic rhinitis

By Selected articles

Meng Y, Wang C, Zhang L.

(2019) Allergy. 2019 Sep 30. doi: 10.1111/all.14067. [Epub ahead of print] Review.

Allergic rhinitis is characterized by symptoms of sneezing, rhinorrhea, nasal obstruction, and pruritus caused by inhaled allergens and involving mucosal inflammation. Allergic rhinitis is a disease with high prevalence all over the world.

This review aimed at highlighting recent developments in the etiology and management of allergic rhinitis.

Exposure of atopic individuals to external environmental factors such as ambient air pollutants, aeroallergens and climate play a crucial role in the pathogenesis of allergic rhinitis. When the nasal mucosa is exposed to inciting allergens such as pollen and dust mites, innate and adaptive immune cells are involved in the pathophysiologic mechanism of allergic rhinitis, which induce specific immunoglobulin E (IgE) production, activation of eosinophils, and degranulation of mast cells and basophils, with the consequent clinical symptoms.

At a cellular and molecular mechanism, several studies reported the role of IL-17 in allergic rhinitis. Serum IL-17 levels are significantly associated with allergy severity during the pollen season and are considered a marker of allergy severity in allergic rhinitis patients.

Current treatment options include patient education, irritant and allergen avoidance measures, pharmacotherapy, allergen immunotherapy, nasal irrigation and other less common measures such as acupuncture and surgery. Recent studies have strengthened the evidence base for the treatment of all aspect of allergic rhinitis.

This document is only available for registered healthcare professionals.

Login
The Role of Mobile Health Technologies in Allergy Care: an EAACI Position Paper.

Quality of Life and Work Productivity Impairment of Patients with Allergic Occupational Rhinitis

By Selected articles

Maher Maoua, et al.

(2019) Tanaffos

Allergic rhinitis impacts negatively the quality of life and occupational activities of patients.

A 10-year duration cross-sectional study evaluated the quality of life and work productivity of patients diagnosed with allergic occupational rhinitis. Quality of Life was assessed by the Mini-RQLQ (rhinitis quality of life questionnaire) and work impairment was assessed by the Work Productivity and Activity Impairment questionnaire.

This study included 414 participants from both genders and with a mean age of 38 years old. Most of them were workers from the textile and clothing industry. Absenteeism was not relevant, however participants experienced activity limitations and practical problems, reducing productivity and quality of life.

This document is only available for registered healthcare professionals.

Login
Rinitis Alergica Local

VAS for assessing the perception of antihistamines use in allergic rhinitis

By Selected articles

Ciprandi G, La Mantia I.

Antihistamines are commonly prescribed for the management of allergic rhinitis and urticaria. The quantification of their consumption is relevant in clinical practice, as their use is usually associated with severe symptoms. In addition, symptomatic use of antihistamines is a useful parameter for evaluating allergen immunotherapy effectiveness. However, the use of a diary for recording the number of tablets is frequently negligenced as patients forget to register the actual quantity of tablets taken.

A visual analogue scale (VAS) measures the patient’s perception of symptom severity, emotions and pain.

This study aimed at measuring the VAS for assessing the patient’s perception about antihistamines use in allergic rhinitis. A total of 103 patients with allergic rhinitis due to Parietaria pollen were retrospectively evaluated. They recorded monthly the number of antihistamine tablets taken during the pollen season.

There was a strong relationship between the number of tablets and the VAS score, which represents a possibility of using VAS to estimate the patient’s perception of antihistamines use in clinical practice.

This document is only available for registered healthcare professionals.

Login
Allergic Rhinitis Nasal Mucosa

ARIA masterclass 2018: From guidelines to real-life implementation

By Selected articles

Hellings PW, Seys SF, Marien G, Agache I, Canonica W, Gevaert P, Haahtela T, Klimek L, Mullol J, Pfaar O, Scadding G, Scadding G, Valiulis A, Aria AMD, Bousquet J, Pugin B; ARIA masterclass discussants.

Around 20-30% of the European populations suffer from allergic rhinitis, which affects their social life, sleep and work productivity, indirectly rising the economic burden for society.

The ARIA (allergic rhinitis and its impact on asthma) initiative has been developing guidelines for the treatment of allergic rhinitis and asthma to ensure the highest level of best practices in real-life settings, and has evolved towards integrated care pathways using mobile technology and further to management as the key to provide an active and healthy life to all allergic rhinitis patients.

In September 2018, the first ARIA masterclass was held in Brussels with the following key objectives:

  • To provide unbiased education on the best-practices for allergic rhinitis diagnosis, treatment and follow-up
  • To update clinicians about recent research data in allergic rhinitis and asthma, from clinical trials to real-world evidence
  • To share next generation care pathways for the optimal management of patients with allergic rhinitis and asthma
  • To inform clinicians about change management and its impact on healthcare
  • To support clinicians with the adoption of digital solutions in daily practice.

A recent study showed that allergic rhinitis specialists behave like patients, showing a real disconnection between physician’s prescription and patient’s behavior for allergic rhinitis treatment.

The majority of allergists prescribe medications for the entire pollen season, but the vast majority of patients use their medications on-demand when their symptoms are not well controlled.

The objective of the ARIA masterclass was to anticipate a reconnection between physicians and patients, by promoting a patient-centered approach, with a therapeutic strategy tailored to the patient needs but also to their preferences. The use of integrated care pathways and mobile Apps can facilitate this change in care management. In turn, this would result in better symptoms controls for patients, and a substantial reduction of indirect cost for the society.

This document is only available for registered healthcare professionals

Login

Identifying an effective mobile health application for the self-management of allergic rhinitis and asthma in Australia

By Selected articles

Tan R, Cvetkovski B, Kritikos V, O’Hehir RE, Lourenço O, Bousquet J, Bosnic-Anticevich S.

Up to 40% of the population worldwide is affected by allergic rhinitis, which carries a significant burden on individuals and society. Allergic rhinitis symptoms are often self-managed in the community pharmacy setting, with patients underestimating their symptoms and overestimating their ability for effective self-management. In the current technology world, the use of mobile Apps has become more and more popular and represents a promising tool for management of different conditions.

The objective of this study was to identify an effective App for the management of allergic rhinitis and/or asthma. All English and free of charge mobile health-related Apps from the Australian Apple store and Android Google Play store were included in this study and evaluated regarding three domains: accessibility in both App stores, alignment with theoretical principles of the self-management of allergic rhinitis and/or asthma and usability of the App using a mobile App rating scale.

Of a total of 418 Apps retrieved, 31 were evaluated. Many of the evaluated Apps fall short of the self-management principles and most within the field of allergic rhinitis and asthma only deal with either one or other condition. The MASK-air App achieved the highest mean rank and covered all self-management principles except a doctor appointment reminder, with a high rate of engagement.

This document is only available for registered healthcare professionals.

Login
The Role of Mobile Health Technologies in Allergy Care: an EAACI Position Paper.

The Role of Mobile Health Technologies in Allergy Care: an EAACI Position Paper

By Selected articles

Matricardi PM, (…)

Mobile Health (mHealth) uses mobile communication devices such as smartphones and tablet computers to support and improve health-related services, data flow and information, patient self-management, surveillance, and disease management from the moment of first diagnosis to an optimized treatment. The European Academy of Allergy and Clinical Immunology created a task force to assess the state of the art and future potential of mHealth in allergology.

This document is only available for registered healthcare professionals.

login
ácaros del polvo

Determination of the minimally important difference in a nasal symptom score in house dust mite allergy

By Selected articles

Devillier P, Brüning H, Bergmann KC.

House dust mite (HDM) allergens are responsible for the most prevalent persistent respiratory allergies. Clinical trials in this field often use a four-component nasal symptom score (T4NSS) as a measure of efficacy.

The MID for improvement in the T4NSS is at least -0.90 units in children, adolescents and adults suffering from HDM-induced AR. This value could be rounded up to -1 unit for convenience.

This document is only available for registered healthcare professionals

Login
conjuntivitis

Local allergic conjunctivitis: a phenotype of allergic conjunctivitis.

By Selected articles

Yamana Y, Fukuda K, Ko R, Uchio E.

Local allergic rhinitis (LAR) has been reported in the field of otolaryngology; however, the concept of local allergic conjunctivitis (LAC) has not been widely studied in the ophthalmologic community. We routinely examined total IgE levels in tear fluids (t-tIgE) and antigen-specific IgE levels in serum (s-sIgE) in patients with suspected allergic conjunctivitis, on the basis of Japanese guidelines for allergic conjunctival diseases. There are several cases in which the results of t-tIgE and s-sIgE testing are divergent. We suggest that these divergent cases correspond to LAR in otolaryngology.

This document is only available for registered healthcare professionals

Login
Rinitis Alergica Local

Nasal Cytology as a Diagnostic Tool for Local Allergic Rhinitis

By Selected articles

Phothijindakul N, Chusakul S, Aeumjaturapat S, Snidvongs K, Kanjanaumporn J, Ruangritchankul K, Phannaso C.

Nasal eosinophilia on nasal cytology was a good screening tool for diagnosing local allergic rhinitis (LAR) because of its high sensitivity and simplicity of the procedure. Unfortunately, the low specificity of nasal eosinophilia makes the nasal provocation test (NPT) necessary for confirmation of LAR.

This document is only available for registered healthcare professionals

Login
Rinitis Alergica

Specific immunoglobulin E in nasal secretions for the diagnosis of local allergic rhinitis

By Selected articles

Meng Y, Wang Y, Lou H, Wang K, Meng N, Zhang L, Wang C.

Chinese investigators hypothesized that local serum specific immunoglobulin E (sIgE) can be used for the diagnosis of local allergic rhinitis instead of nasal allergen provocation test.

This prospective single center study included 73 chronic rhinitis patients with negative findings for serum IgE and positive findings for local eosinophils and 10 healthy patients were used as controls. All participants completed questionnaires to record demographic data, nasal symptom severity and physician-diagnosed comorbid asthma.

A visual analogue scale of 10 cm was used to record symptom severity and the allergic status was assessed by serum IgE. Nasal secretions were collected for analysis of local sIgE and eosinophils and nasal allergen provocation test was performed to confirm local allergic rhinitis.

Fourteen patients demonstrated positive local sIgE, with twelve of them having significantly higher local sIgE levels and positive nasal allergen provocation test compared to controls.

In conclusion, the measurement of local sIgE levels in nasal secretions is a reliable and effective diagnostic method for local allergic rhinitis as its sensitivity, specificity and diagnostic accuracy was over 90%.

 

 

 

This document is only available for registered healthcare professionals

Login
control de la rinitis

Adaptation to Spanish and validation of the Rhinitis Control Assessment Test (RCAT) questionnaire

By Selected articles

Del Cuvillo A, Sastre J, Colás C, Navarro AM, Mullol J, Valero A.

Spanish investigators developed and validated a national version of the rhinitis control assessment test. This test is widely used to evaluate control of patients with allergic rhinitis.

They translated and adapted the original questionnaire to Spain and prospectively evaluated its properties in regard to its validity, reliability, responsiveness, size effect, minimal important difference and cut point score.

A total of 252 allergic rhinitis patients were included. Investigators found significant and strong correlations between the Spanish rhinitis control assessment test and the total nasal symptom score and the visual analogue scale. This assessment test managed to distinguish between patients with different severity or duration of allergic rhinitis and it also linearly correlated with the improvement of allergic rhinitis.

In conclusion, the adaptation to Spanish-speaking allergic rhinitis patients was successful and can be effectively used to measure control of allergic rhinitis symptoms.

This document is only available for registered healthcare professionals

Login
Cepillado nasal

Nasal mucosal brushing as a diagnostic method for allergic rhinitis

By Selected articles

Hamizan A, Alvarado R, Rimmer J, Sewell WA, Barham HP, Kalish L, Harvey

Allergen specific immunoglobulin E (spIgE) in the nasal mucosa is a biomarker for local allergic rhinitis. Inferior turbinate tissue biopsy is a sensitive method to detect nasal spIgE but is invasive. Nasal brushing is a relatively noninvasive method to detect nasal spIgE that may be of comparable diagnostic utility.

Nasal brushing constituted an easy and relatively noninvasive method to sample nasal epithelium. This sampling technique was comparable with an inferior turbinate tissue biopsy and may be developed as a diagnostic tool for the diagnosis of local allergic rhinitis.

This document is only available for registered healthcare professionals

Login
Terapia combinada de azelastina intranasal y propionato de fluticasona

Intranasal azelastine and fluticasone as combination therapy for allergic rhinitis: therapy for allergic rhinitis: systematic review and meta-analysis

By Selected articles

Peter M. Debbaneh, Anna K. Bareiss, Sarah K. Wise and Edward D. McCoul

(2019) Otolaryngology – Head and Neck Surgery

La terapia de combinación con azelastina intranasal y propionato de fluticasona es una opción para el tratamiento de la rinitis alérgica. Esta revisión sistemática y meta-análisis examina la literatura existente para determinar la eficacia en el tratamiento de la rinitis alérgica en comparación con la monoterapia.

This document is only available for registered healthcare professionals

Login
Epigenética

Epigenetic changes: An emerging potential pharmacological target in allergic rhinitis

By Selected articles

Yang J, Zhong W, Xue K, Wang Z.

The importance of epigenetics has increased due to identification of its role in the pathophysiology of a number of diseases including allergic rhinitis. This review discusses the studies describing the epigenetic changes taking place in the host cells in response to allergen along with possible mechanisms.

This document is only available for registered healthcare professionals

Login
Diario de Alergias

Mobile technology offers novel insights on control and treatment of allergic rhinitis. The MASK study.

By Selected articles

Bédard A, (…); MASK study group.

A cross-sectional real-world observational study took place in 22 countries to complement a pilot study and provide new information on medication use, disease control and work productivity in people with allergic rhinitis.

A mobile phone app (“Allergy diary”, available for free on Google Play and Apple store) was used to collect data of daily visual analogue scale scores for overall allergic symptoms, nasal, ocular and asthma symptoms, work and medication used by choosing from a list that included all allergic rhinitis medications (prescribed and over-the-counter) available in 22 countries.

The 4 most common intranasal medications containing intranasal corticosteroids and 8 oral antihistamines were considered for the study.

9,122 people who used the mobile application filled the equivalent to 112,054 days of visual analogue scale scores in 2016 and 2017. All other assessments were informative. Users with allergic rhinitis selected between none, single, or multiple treatments, with those referring multiple treatments corresponding to the worst control of symptoms and increasing the range of treatments used.

The analysis also revealed a similar trend for asthma, eye symptoms and work productivity.

Conclusively, although differences between oral antihistamines were found, this study confirms the usefulness of the application Allergy Diary in accessing and assessing behaviour of people with allergic rhinitis.

This document is only available for registered healthcare professionals

Login
Close Menu

La información que está a punto de visualizar está dirigida únicamente a los profesionales sanitarios aptos para prescribir o dispensar medicamentos. La correcta utilización de su contenido requiere de formación como profesional sanitario.

Debe hacer clic en Aceptar para confirmar que es usted profesional de la salud y continuar con la navegación.

ACEPTAR